Last reviewed · How we verify

NCT05851482: HRM nomogram

Validation of HRM Score for the GERD Diagnosis

Completed NA Last updated 9 May 2023
What this trial tests

NA trial testing High resolution manometry in Gastro Esophageal Reflux in 246 participants. Completed in 29 April 2023.

Timeline
1 December 2022
Primary endpoint
28 February 2023
29 April 2023

Quick facts

Lead sponsorIRCCS Policlinico S. Donato
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment246
Start date1 December 2022
Primary completion28 February 2023
Estimated completion29 April 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Policlinico S. Donato

Who can join

Adults 18 to 75, any sex, with Gastro Esophageal Reflux. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective study is to validate a high resolution manometry score to predict pathologic GERD in patients with reflux symptoms. The main question it aims to answer is: Is it possible to predict GERD on high resolution manometry? Participants will be asked to undergo high resolution manometry and pH-study

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Milan score: A novel manometric tool for a more efficient diagnosis of gastro-esophageal reflux disease.
    Siboni S, Sozzi M, Kristo I, Boveri S, et al · · 2024 · cited 28× · PMID 38536701 · DOI 10.1002/ueg2.12565

Verify or expand the search:

Other recruiting trials for Gastro Esophageal Reflux

Currently open trials in the same condition.

Other IRCCS Policlinico S. Donato trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05851482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing